In conclusion, our study highlights the significance of NRP1 expression regulation, and the natural product CD downregulated the expressions not only in NRP1 but also in immune molecules such as A2AR, implying a NRP1 mechanism probably through immuno-response pathways, providing a potential CD therapy for anti-cancer and anti-viral diseases, including COVID-19. This evidence concerns the gene ADORA2A and viral infectious disease.